|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0011860,
umls-concept:C0030705,
umls-concept:C0031809,
umls-concept:C0034656,
umls-concept:C0035648,
umls-concept:C0061323,
umls-concept:C0246689,
umls-concept:C0311400,
umls-concept:C0332307,
umls-concept:C0549193,
umls-concept:C1707455
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-5-16
|
|
pubmed:abstractText |
Repaglinide and glimepiride are relatively new oral hypoglycemic agents. Few data are available concerning their effects on metabolic parameters other than measures of glycemic control.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
472-84
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12749508-Blood Glucose,
pubmed-meshheading:12749508-Blood Pressure,
pubmed-meshheading:12749508-Carbamates,
pubmed-meshheading:12749508-Diabetes Mellitus, Type 2,
pubmed-meshheading:12749508-Double-Blind Method,
pubmed-meshheading:12749508-Female,
pubmed-meshheading:12749508-Homocysteine,
pubmed-meshheading:12749508-Humans,
pubmed-meshheading:12749508-Hypoglycemic Agents,
pubmed-meshheading:12749508-Lipoprotein(a),
pubmed-meshheading:12749508-Male,
pubmed-meshheading:12749508-Middle Aged,
pubmed-meshheading:12749508-Piperidines,
pubmed-meshheading:12749508-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:12749508-Risk Factors,
pubmed-meshheading:12749508-Sulfonylurea Compounds,
pubmed-meshheading:12749508-Time Factors,
pubmed-meshheading:12749508-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors.
|
|
pubmed:affiliation |
Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. giuderosa@tin.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
